Ronald Asbury Andrews, Chief Executive Officer at OncoCyte Corp (OCX), bought 11,000 shares at $4.79 ($53K) on 2021-03-19, disclosed to the SEC on 2021-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OCX | BUY | 2020-08-04 | $54K | — | Filing → |
| OCX | BUY | 2020-04-01 | $42.7M | — | Filing → |
| OCX | BUY | 2020-04-01 | $208K | — | Filing → |